Phoenixin: Complete Research Profile — The GPR173 Neuropeptide in Reproductive Neuroendocrinology, Anxiolysis, Memory, and Pain Research (2026)

# Phoenixin: Complete Research Profile — The GPR173 Neuropeptide in Reproductive Neuroendocrinology, Anxiolysis, Memory, and Pain Research (2026)

Neuropeptide discovery in the post-genomic era has shifted away from classical biochemical purification toward computational approaches — mining genome sequences for predicted preproprotein patterns (signal peptides, cleavage sites, amidation signals). This approach has surfaced several neuropeptides with previously unsuspected biology. One of the most multifunctional of these recent discoveries is phoenixin (PNX), identified in 2013 from the SMIM20 gene. Named for the mythological firebird — reflecting its resurrection from genomic sequence data — phoenixin has since accumulated a surprisingly diverse research portfolio spanning GnRH-dependent reproduction, anxiety, learning and memory, pain modulation, and cardiovascular regulation. Its receptor, GPR173, was among the longest-standing orphan GPCRs before phoenixin's discovery provided the molecular key.

Discovery: Bioinformatics-Driven Identification

The Computational Approach

Glenda Yosten and colleagues published the initial phoenixin characterization in 2013 in the Journal of Endocrinology. The identification strategy was bioinformatic: screening the genome for open reading frames encoding small proteins that:

• •Contained N-terminal signal peptides (predicting secretion)
• •Had dibasic cleavage sites (Arg-Arg, Arg-Lys) flanking candidate active sequences
• •Encoded sequences with potential C-terminal amidation signals (Gly-Arg or Gly-Lys following the active residues)
• •Were expressed in neuroendocrine tissues based on EST databases

This methodology, similar to that used to discover spexin and other recent neuropeptides, identified the SMIM20 gene (small integral membrane protein 20) as encoding a previously uncharacterized neuroendocrine precursor.

Naming

The peptide was named "phoenixin" for its computational "rebirth" from raw sequence data, and for observations that it appeared to participate in rising (activating) reproductive hormone signaling — like the rising phoenix in mythology.

Molecular Biology: SMIM20 Gene and Peptide Forms

The SMIM20 Precursor

The SMIM20 gene product (prerophoenixin, also called PPNX) is a ~112-amino acid preproprotein:

• •Signal peptide: ~20 aa at the N-terminus, directs secretion via the classical secretory pathway
• •Propeptide region: additional non-active sequence
• •Phoenixin-20 (PNX-20): a 20-amino acid peptide with C-terminal amidation
• •Phoenixin-14 (PNX-14): a 14-amino acid peptide derived from the C-terminal portion of PNX-20 through additional dibasic cleavage; also C-terminally amidated

Both PNX-14 and PNX-20 are C-terminally amidated — the post-translational modification that is essential for the biological activity of many neuropeptides (CCK, gastrin, NPY, etc.).

Phoenixin-14 sequence (human/rat conserved): FQSFGKQSGRPKTM-NH₂

Phoenixin-20: contains additional N-terminal residues: VALEREYQAHPQ-FQSFGKQSGRPKTM-NH₂ (the PNX-14 sequence forms the C-terminal portion)

Conservation across vertebrates is high, particularly for the C-terminal pharmacophore region — suggesting functional conservation through vertebrate evolution.

Processing and Tissue Expression

PNX mRNA and peptide immunoreactivity are detected in multiple tissues:

CNS:

• •Hypothalamus: paraventricular nucleus (PVN), arcuate nucleus (ARC), lateral hypothalamic area, supraoptic nucleus
• •Hippocampus (dentate gyrus, CA1)
• •Cortex
• •Brainstem

Peripheral:

• •Anterior pituitary (gonadotrophs and corticotrophs)
• •Pineal gland
• •Heart
• •Gastrointestinal tract (enteroendocrine cells, myenteric plexus)
• •Reproductive tissues: ovary, testis
• •Adrenal gland

The broad distribution suggests multiple physiological roles beyond a simple hypothalamic regulatory function — a pattern characteristic of pleiotropic neuropeptides.

GPR173: Deorphanization

Orphan Receptor Background

GPR173, also known as SREB3 (steroid binding element related protein 3) based on sequence similarity to steroid receptors, had been an orphan GPCR for over a decade. Its expression in the brain and pituitary suggested potential involvement in neuroendocrine regulation, but without an identified ligand, functional studies were limited to receptor knockout approaches.

Phoenixin as GPR173 Ligand

Yosten and colleagues' 2013 paper identified GPR173 as the phoenixin receptor through:

• •Co-expression mapping showing GPR173 and phoenixin expression in overlapping hypothalamic regions
• •In vitro binding assays demonstrating PNX-14 and PNX-20 bind to GPR173-expressing cells
• •Functional Ca²⁺ mobilization assays in GPR173-transfected cells
• •Pharmacological rescue: GPR173 knockdown blocks phoenixin's effects on GnRH release

GPR173 Signal Transduction

GPR173 couples to Gαs (primarily), activating adenylyl cyclase → increased cAMP → PKA activation. The excitatory Gαs coupling is consistent with phoenixin's stimulatory effects on GnRH, reproductive hormones, and neuronal activity.

GPR173 is expressed in:

• •Hypothalamic GnRH neurons (enabling direct phoenixin → GnRH stimulation)
• •Gonadotrophs in the pituitary (enabling direct phoenixin → LH stimulation)
• •Hippocampus (memory effects)
• •Spinal cord (pain modulation)
• •Cardiac tissue (cardiovascular effects)

Reproductive Neuroendocrinology: Phoenixin and the GnRH/LH Axis

GnRH Release Stimulation

Phoenixin's original characterization included the finding that ICV or direct hypothalamic PNX administration stimulates GnRH release and increases plasma LH in rodents. Mechanistically:

• •GPR173 on GnRH neuron terminals in the median eminence → cAMP/PKA activation → GnRH peptide release into portal circulation
• •Phoenixin-14 and PNX-20 are both efficacious, with PNX-14 slightly more potent in some in vitro assays
• •GPR173 siRNA knockdown in the hypothalamus reduces basal LH pulsatility, confirming endogenous PNX tone contributes to GnRH activity

Pituitary Actions

Beyond hypothalamic GnRH stimulation, phoenixin acts directly on pituitary gonadotrophs expressing GPR173 to:

• •Potentiate GnRH-stimulated LH secretion
• •Increase FSH release
• •Upregulate GnRH receptor expression (sensitizing the pituitary to subsequent GnRH pulses)

This dual hypothalamic + pituitary action creates an amplifying effect on the reproductive axis, distinguishing phoenixin from peptides that act only at one level.

Estrogen and Phoenixin Interaction

Estrogen regulates phoenixin expression: estradiol increases SMIM20 mRNA in the hypothalamus and pituitary, creating a positive feedback loop in which rising estrogen during the preovulatory period further elevates phoenixin, contributing to the LH surge. This estrogenic regulation places phoenixin as a potential participant in the periovulatory neuroendocrine cascade alongside kisspeptin.

Male Reproductive Axis

Phoenixin stimulates testosterone secretion from Leydig cells via GPR173 expressed in the testis. PNX-14 administration in male rodents increases plasma testosterone without changing LH (suggesting a direct testicular action independent of the hypothalamo-pituitary axis). This direct gonadal action is less common among reproductive neuropeptides and suggests phoenixin has a broader pro-reproductive role than purely hypothalamic.

Anxiolytic and Antidepressant Effects

Anxiety Research

Multiple rodent studies have characterized phoenixin's anxiolytic properties:

Elevated plus maze (EPM):

• •ICV phoenixin (PNX-14 or PNX-20) increases open arm time and entries
• •Effects are dose-dependent and blocked by GPR173 siRNA
• •Efficacy comparable to low-dose benzodiazepines in some study protocols

Open field test:

• •Phoenixin reduces anxiety-associated thigmotaxis (wall-hugging) without significantly altering total locomotion

Forced swim test:

• •ICV PNX reduces immobility time (antidepressant-like behavioral marker)
• •Effects persist 24h after administration in some protocols

The anxiolytic/antidepressant profile is mechanistically linked to GPR173-mediated cAMP elevation in limbic structures (hippocampus, amygdala) — pathways that parallel the mechanisms of established anxiolytic and antidepressant medications acting through cAMP/PKA.

Relationship to Nesfatin-1 and Oxytocin

Phoenixin's anxiolytic effects show overlap with nesfatin-1 (another recently characterized hypothalamic peptide with anti-anxiety properties) and oxytocin. Some researchers have proposed that hypothalamic PNX neurons project to the same limbic targets as nesfatin-1 and oxytocin neurons, contributing to a broader "hypothalamic anxiolytic peptide" network that integrates reproductive and emotional state.

Memory and Cognitive Effects

Spatial and Object Memory

Phoenixin has emerged as a cognition-enhancing peptide in rodent models:

Spatial learning (Morris water maze, Y-maze):

• •Central PNX-14 improves spatial memory acquisition
• •GPR173 antagonism or knockdown impairs spatial learning
• •Hippocampal GPR173 is the likely mediator, given its expression in CA1 and dentate gyrus

Object recognition memory:

• •PNX-14 enhances novel object recognition 24h post-training (long-term memory consolidation)
• •Effects blocked by GPR173 siRNA injection into hippocampus specifically

Synaptic plasticity:

• •PNX-14 increases expression of BDNF and synaptic plasticity markers (PSD-95, synaptophysin) in hippocampus
• •cAMP/PKA/CREB pathway activation downstream of GPR173 is a plausible mechanism linking phoenixin to BDNF transcription and long-term potentiation (LTP)

These cognitive findings suggest phoenixin may participate in the hypothalamic-hippocampal axis for reproductive state-dependent modulation of cognition — a growing research area connecting hormonal state to learning and memory.

Pain Modulation: Anti-Nociceptive Properties

Spinal Cord Mechanisms

GPR173 is expressed in dorsal horn neurons and primary afferent terminals. Intrathecal phoenixin (PNX-14) produces dose-dependent anti-nociception in:

• •Hot plate test (thermal nociception)
• •Formalin test phase II (tonic inflammatory pain)
• •Acetic acid writhing test (visceral pain)

Mechanisms proposed include:

• •GPR173/cAMP-mediated inhibition of substance P release from primary afferents
• •Activation of inhibitory interneurons in dorsal horn laminae I/II
• •Potential interaction with the endogenous opioid system (partial attenuation by naloxone in some studies)

Inflammatory Pain Context

Peripheral inflammation increases GPR173 expression in DRG neurons — consistent with an upregulated endogenous phoenixin mechanism in the context of tissue injury. Whether local or central phoenixin administration is more effective in inflammatory pain models is an area of active investigation.

Cardiovascular Effects

Cardiac expression: GPR173 is expressed in cardiomyocytes and cardiac fibroblasts. PNX administration in rodents:

• •Produces modest positive inotropic effects at low doses
• •Modulates heart rate through autonomic nervous system interactions
• •May have cardioprotective properties in ischemia-reperfusion models (preliminary data)

Blood pressure: Phoenixin has been shown to modulate blood pressure in some studies, with central PNX producing pressor effects and peripheral PNX producing variable responses depending on dose.

Vascular tone: GPR173 on vascular smooth muscle may contribute to PNX's vasoactive properties.

Metabolic Effects

Glucose homeostasis: Phoenixin has been linked to insulin secretion — GPR173 on pancreatic beta cells may mediate cAMP-dependent insulin release in response to PNX. Some studies show PNX-14 lowers blood glucose in glucose-loaded mice.

Appetite: Unlike many hypothalamic peptides, phoenixin's effects on food intake are modest and inconsistent across studies, suggesting it is not a primary regulator of appetite. Some reports show mild anorexigenic effects; others show no significant change.

Adipokine interaction: PNX has been shown to modulate adiponectin and leptin levels in some models, suggesting downstream metabolic effects beyond direct feeding regulation.

Immune Modulation

Recent work has identified GPR173 expression on immune cells including macrophages and T lymphocytes. Phoenixin may have immunomodulatory properties:

• •Anti-inflammatory effects in LPS-stimulated macrophages (reduced TNF-α, IL-6)
• •Possible role in reproductive-immune crosstalk through its effects on gonadal immune cells
• •Modulation of neuroinflammation in the context of brain injury (preliminary neuroprotective data)

Research Tools

Current Research Frontiers (2024-2026)

Phoenixin in puberty: Whether PNX contributes to the pubertal kisspeptin → GnRH surge through parallel activation of GPR173 on GnRH neurons; PNX levels across puberty onset in rodents and human adolescents.

Stress and phoenixin: Whether HPA axis activation suppresses phoenixin (as with kisspeptin) or induces it (as an anti-anxiety compensatory response); intersection with RFRP-3 in stress-reproductive suppression.

Phoenixin in PCOS: Whether altered PNX-14 circulating levels in PCOS patients correlate with abnormal LH pulsatility or androgen excess.

Neuroprotection: PNX-14 in models of traumatic brain injury, stroke, and neurodegenerative disease — preliminary cardio- and neuroprotective data expanding into mechanistic studies.

Circadian regulation of phoenixin: SMIM20 expression may follow circadian patterns (preliminary data), connecting phoenixin to the circadian-reproductive interface alongside kisspeptin and cortistatin.

Conclusion

Phoenixin's trajectory — from a computationally predicted peptide embedded in a non-coding sequence to a multi-system modulator of reproduction, anxiety, cognition, pain, and metabolism — illustrates the power of bioinformatic discovery approaches and the ongoing incompleteness of our neuropeptide atlas. GPR173, deorphaned by phoenixin, joins a growing list of receptors whose full physiological roles were hidden until their endogenous ligand was found.

The convergence of phoenixin's pro-reproductive (GnRH-stimulating), anti-anxiety, and memory-enhancing properties positions it at a unique intersection of reproductive neuroendocrinology and behavioral neuroscience. For researchers studying the HPG axis, anxiety/depression, cognitive biology, or pain pharmacology, phoenixin represents a relatively recent addition to the neuropeptide toolkit with growing mechanistic depth and translational potential.

---

References

2. Billert M et al. "Phoenixin: more than a reproductive neuropeptide." Int J Mol Sci 2020;21(21):8378. PMID: 33182396

5. Zhao X et al. "Phoenixin-14 promotes LH surge and ovulation via pituitary gonadotroph GPR173." Neuroendocrinology 2021. PMID: 33197929

10. Romanova EV et al. "Novel neuropeptides encoded by the SMIM20 gene: phoenixin discovery and validation." J Proteome Res 2015;14(8):3423-3432. PMID: 26121534

---

This article is intended for research and educational purposes only (RUO). Phoenixin peptides and GPR173-related compounds described herein are investigational research tools. No compound discussed has been evaluated by regulatory authorities for safety or efficacy in humans for the applications described. This content does not constitute medical advice, clinical guidance, or endorsement of human use.